Seftza TZ 250mg/31.25mg Injection
Marketer
Ultratech Pharmaceuticals
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Seftza TZ 250mg/31.25mg Injection
Tazicef 250mg/31.25mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this injection solely under a physician's guidance; strictly adhere to the prescribed dosage schedule. Complete the full course of treatment, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms to your doctor immediately. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require medical consultation before use. Alcohol consumption should be avoided due to potential additive drowsiness. While it typically doesn't affect driving ability, refrain from operating vehicles if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration promote optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Seftza TZ 250mg/31.25mg Injection
No text provided. Please provide the text you want me to rewrite.
Uses of Seftza TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Seftza TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Seftza TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Seftza TZ 250mg/31.25mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
How Seftza TZ 250mg/31.25mg Injection works:
Seftza TZ Injection, containing 250mg Ceftazidime and 31.25mg Tazobactam, utilizes a dual-drug approach to combat bacterial infections. Ceftazidime, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise inactivate Ceftazidime, thereby augmenting its antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Seftza TZ 250mg/31.25mg Injection may be taken with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Seftza TZ 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Seftza TZ 250mg/31.25mg Injection poses no known breastfeeding safety risk. Research in humans indicates minimal drug transfer to breast milk, presenting negligible harm to the infant.
DrivingUNSAFE
The administration of Seftza TZ 250mg/31.25mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Seftza TZ 250mg/31.25mg Injection. A modified dosage of Seftza TZ 250mg/31.25mg Injection may be necessary. Medical advice is recommended.
LiverCAUTION
The injectable medication Seftza TZ 250mg/31.25mg requires careful administration for individuals with significant hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Seftza TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Seftza TZ 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Seftza TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently